What is Medi-Caps share price return in the past 10 years?

Medi-Caps Ltd share price has appreciated 11.8% annually (CAGR) over the past ten years.

Medi-Caps Ltd - Stock Valuation and Financial Performance

Name: Medi-Caps
Brand: Medi-Caps

BSE: 523144 | NSE: MEDICAPS | Chemicals | Small Cap

Place order

Medi-Caps Share Price

₹50 -0.10 -0.20%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Medi-Caps

Based on:

Data

M-Cap below 100cr DeciZen not available

Medi-Caps stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

25.46

Market Cap:

62.4 Cr.

52-wk low:

40.6

52-wk high:

63.5

Is Medi-Caps Ltd an attractive stock to invest in?

1. Is Medi-Caps Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Medi-Caps Ltd is a below average quality company.

2. Is Medi-Caps Ltd undervalued or overvalued?

The key valuation ratios of Medi-Caps Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Medi-Caps Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Medi-Caps Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Medi-Caps:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	4.3%	2.7%	2.3%	1.2%	1.1%	-13%	0%	-0.1%	0.4%	7.6%	-
Value Creation Index ⓘ	-0.7	-0.8	-0.8	-0.9	-0.9	-1.9	NA	-1.0	-1.0	-0.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	27.4	25	22.8	22.4	21.6	10.9	0	0	0.1	7.2	6
Sales YoY Gr.	-	-8.5%	-9.1%	-1.8%	-3.3%	-49.5%	-100%	NA	NA	7,070%	-
Adj EPS ⓘ	1.2	0.9	0.9	0.5	0.5	-6.7	0	-0.1	0.2	3.1	2
YoY Gr.	-	-18.3%	-1.1%	-51.6%	6.7%	-1489.6%	NA	NA	NA	1385.7%	-
BVPS (₹) ⓘ	51.6	52.6	53.2	53.7	54.1	48	48.9	49.2	49	53.3	54.2
Adj Net Profit ⓘ	1.4	1.2	1.2	0.6	0.6	-8.3	0	-0.1	0.3	3.9	2
Cash Flow from Ops. ⓘ	6.9	1.4	2.7	0.9	1.3	-0.9	2.2	-1	-2.6	3.1	-
Debt/CF from Ops. ⓘ	0	0	0	0.2	0.1	-0.1	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-13.8%	-19.8%	NA	7070%
Adj EPS ⓘ	11.7%	45.4%	NA	1385.7%
BVPSⓘ	0.4%	-0.3%	2.9%	8.8%
Share Price	11.8%	34.6%	2.2%	8.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	2.3	1.8	1.8	0.8	0.9	-13.1	-0.2	0.4	6.1	3.7
Op. Profit Mgn % ⓘ	6.8	6.5	3.5	2	-0	-83.1	0	-289.2	67.6	52.8
Net Profit Mgn % ⓘ	5.2	4.7	5.1	2.5	2.8	-76.3	0	253.7	54.3	40.3
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	221	215	235	209	223	297	0	21,080	454	785
Cash Conv. Cycle ⓘ	147	161	166	144	148	191	0	8,062	176	764

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 3.60%

Sales growth has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at -13.63%

Latest Financials - Medi-Caps Ltd.

	Standalone	Consolidated
TTM EPS (₹)	2	-1.2
TTM Sales (₹ Cr.)	6.1	28.8
BVPS (₹.) ⓘ	54.2	99.2
Reserves (₹ Cr.) ⓘ	54	111
P/BV ⓘ	0.92	0.50
PE ⓘ	25.46	0.00

From the Market
52 Week Low / High (₹)	40.56 / 63.49
All Time Low / High (₹)	0.12 / 91.15
Market Cap (₹ Cr.)	62.4
Equity (₹ Cr.)	12.5
Face Value (₹)	10
Industry PE ⓘ	57.2

Management X-Ray of Medi-Caps:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Medi-Caps

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Medi-Caps

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	27.36	25.04	22.76	22.35	21.62	10.91	0	0	0.10	7.17
Operating Expenses ⓘ	25.50	23.41	21.99	21.92	21.66	19.98	0	0.56	0.39	2.33
Manufacturing Costs	5.62	5.42	4.63	4.60	4.63	3.26	0	0.01	0.01	0.12
Material Costs	12.62	10.71	9.84	9.60	9.52	9.25	0	0	0	0.01
Employee Cost	4.15	4.47	4.46	4.57	4.59	5.55	0	0.45	0.23	0.50
Other Costs ⓘ	3.12	2.81	3.06	3.16	2.92	1.92	0	0.10	0.16	1.69
Operating Profit ⓘ	1.86	1.63	0.77	0.44	-0.04	-9.07	0	-0.56	-0.29	4.84
Operating Profit Margin (%)	6.8%	6.5%	3.4%	2.0%	-0.2%	-83.2%	-	-	-289.0%	67.6%
Other Income ⓘ	1.21	0.46	1.13	0.68	1.14	1.12	0	0.61	0.64	0.15
Interest ⓘ	0.01	0.01	0.02	0.02	0.04	0.01	0	0.01	0	0
Depreciation ⓘ	0.32	0.33	0.37	0.34	0.35	0.36	0	0.09	0.09	0.16
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	2.73	1.74	1.51	0.76	0.71	-8.32	0	-0.06	0.26	4.83
Tax ⓘ	0.80	0.56	0.35	0.20	0.12	0.01	-0.01	0.01	0	0.94
Profit After Tax	1.94	1.18	1.16	0.56	0.59	-8.33	0.01	-0.08	0.26	3.89
PAT Margin (%)	7.1%	4.7%	5.1%	2.5%	2.7%	-76.3%	-	-	253.6%	54.3%
Adjusted EPS (₹)	1.6	1.0	0.9	0.5	0.5	-6.7	0.0	-0.1	0.2	3.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	64.36	65.54	66.37	66.92	67.51	59.85	60.97	61.29	61.11	66.49
Share Capital ⓘ	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47
Reserves ⓘ	51.89	53.07	53.90	54.45	55.04	47.38	48.50	48.82	48.64	54.02
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0	0	0.17	0.12	0.06	0	0	0	0
Long Term Debt	0	0	0	0.12	0.06	0	0	0	0	0
Short Term Debt	0	0	0	0.05	0.06	0.06	0	0	0	0
Trade Payables	1.22	1.87	2.24	1.47	3.08	0.42	0.03	0	0	0.01
Others Liabilities ⓘ	3.37	3.60	3.39	3.25	3.07	1.22	1.63	0.52	0.52	1.60
Total Liabilities ⓘ	68.95	71.01	72.01	71.82	73.78	61.55	62.64	61.81	61.63	68.09
Fixed Assets
Gross Block	20.36	20.36	20.93	21.33	21.65	21.65	21.13	19.99	16.99	16.95
Accumulated Depreciation	16.40	16.73	17.05	17.39	17.74	18.02	17.88	17.22	14.53	14.69
Net Fixed Assetsⓘ	3.96	3.64	3.88	3.93	3.91	3.63	3.26	2.78	2.46	2.26
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	48.25	49.56	50.37	50.89	51.75	52.15	53.31	53.68	51.98	55.11
Inventories	7.06	7.74	7.60	5.76	6.95	0.53	0.05	0	0	0.03
Trade Receivables	6.64	6.61	6.06	6.94	6.25	2.66	2.41	2.24	2.24	4.65
Cash Equivalents	0.90	1.03	1.97	2.04	2.13	0.75	0.73	0.79	0.04	0.05
Others Assetsⓘ	2.14	2.43	2.13	2.25	2.79	1.83	2.89	2.33	4.91	6
Total Assets ⓘ	68.95	71.01	72.01	71.82	73.78	61.55	62.64	61.81	61.63	68.09

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	6.88	1.44	2.70	0.86	1.33	-0.92	2.24	-0.95	-2.60	3.09
PBT ⓘ	2.73	1.74	1.51	0.76	0.71	-8.32	-0.12	-0.06	0.26	4.83
Adjustment ⓘ	0.32	0.33	0.37	0.34	0.35	0.94	1.57	0.58	-0.28	1.65
Changes in Working Capital ⓘ	4.58	-0.09	1.15	-0.07	0.37	6.45	0.79	-1.47	-2.57	-2.44
Tax Paid ⓘ	-0.75	-0.54	-0.33	-0.18	-0.10	0	0	0	0	-0.95
Cash Flow From Investing Activity ⓘ	-6.78	-1.31	-1.76	-0.96	-1.19	-0.40	-2.19	1.01	1.85	-3.09
Capex	-0.30	0	-0.61	-0.40	-0.33	0	0.04	0.30	0.15	0.04
Net Investments	-6.50	-1.31	-1.15	-0.56	-0.86	-0.41	-2.23	0.71	1.70	-3.13
Others ⓘ	0.01	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	0	0	0	0.17	-0.05	-0.06	-0.06	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0.17	-0.05	-0.06	-0.06	0	0	0
Net Cash Flow ⓘ	0.10	0.13	0.94	0.07	0.09	-1.38	-0.02	0.06	-0.75	0

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	3.05	1.82	1.75	0.85	0.88	-13.08	0.01	-0.12	0.42	6.09
ROCE (%)	4.33	2.7	2.33	1.17	1.11	-13.03	0	-0.08	0.42	7.57
Asset Turnover Ratio	0.44	0.4	0.35	0.37	0.35	0.19	0	0	0	0.11
PAT to CFO Conversion(x)	3.55	1.22	2.33	1.54	2.25	N/A	224	N/A	-10	0.79
Working Capital Days
Receivable Days	88	87	91	88	95	126	0	0	8,063	175
Inventory Days	75	97	111	91	92	106	0	0	0	2
Payable Days	35	53	76	71	87	69	0	0	0	152

Medi-Caps Ltd Stock News

Medi-Caps Ltd FAQs

What is the share price of Medi-Caps?

Company share prices are keep on changing according to the market conditions. The closing price of Medi-Caps on 20-Dec-2024 16:59 is ₹50.00.

What is the market cap of Medi-Caps?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Medi-Caps stood at ₹62.35.

What is the P/E ratio of Medi-Caps?

The latest P/E ratio of Medi-Caps as of 20-Dec-2024 16:59 is 25.46.

What is the P/B ratio of Medi-Caps?

The latest P/B ratio of Medi-Caps as of 20-Dec-2024 16:59 is 0.92.

What is the 52-week high and low of Medi-Caps?

The 52-week high of Medi-Caps is ₹63.49 and the 52-week low is ₹40.56.

What is the TTM revenue of Medi-Caps?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medi-Caps is ₹6.06 ( Cr.) .

About Medi-Caps Ltd

Medi-Caps incorporated in 1986 is a flagship company of Medi-Caps Group, is one of the largest manufacturer of empty hard gelatin capsules in terms of manufacturing capacity as well as market capitalization in India. Medi-Caps entered the highly competitive market with a team of dedicated professionals, duly supported by competent individuals in every aspect of operation.

Medi-Caps Groupâ€™s activities span manufacturing of Hard Gelatin Capsule Shells, Education, Industrial Packaging & related products, Finance, Real Estate and is a renowned name in central India.

Medi-Caps Institute of Technology and Management (MITM)
Medi-Caps Finance Limited
International Institute of Foreign Trade and Research (IIFTR)
Medpak India Limited
Trapti Investments (P) Limited
Mittal Enterprises
Akshit Finance (P) Limited

At Medi-Caps a philosophy of growth has been consistently upheld with good business practices. Clear focus, excellent infrastructure, a powerful quality policy and a well defined management information system have helped the company to achieve consistent growth. Today they offer printing features that are best in the industry. Medi-Caps has pioneered many advanced features in product development such as â€œPearlz Capsulesâ€ (Metallic Colored) as well as Python Printing & Li-Fill Caps.

Medi-Caps Limited continuously strives to offer its customers excellent product, technical advice, and a through professional service that makes their product tailor made for their customers both in India as well as abroad.

Their professional goals and corporate personality have blended so well that today Medi-Caps name has become synonymous with the best in the Industry.

Product range of the company includes:

The product product range comprises of six sizes ranging from 00,0el, 0, 1el, 1,2,3,4 in more than 1000 shades, the same is increasing as rapidly as Pharma Industry itself.